Synchron has reeled in another $200 million in a series D round—cash the company said it will use to expand operations and accelerate commercialization of its nonsurgical brain-computer interface (BCI ...
NEW YORK--(BUSINESS WIRE)--Synchron, a leader in non-surgical brain-computer interface (BCI) technology, announced today it has raised a $200 million Series D financing round. The funding will ...
Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego Synchron, a leader in non-surgical brain-computer interface ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback